The study aims to establish an orthotopic liver cancer model in nude mice and evaluate the anti-tumour efficacy of Sorafenib.
Liver cancer is a leading cause of cancer deaths worldwide, accounting for approximately 830,000 deaths each year.
To read more, please download this free white paper.